Combination of UGT1A1 polymorphism and baseline plasma bilirubin levels in predicting the risk of antipsychotic-induced dyslipidemia in schizophrenia patients https://www.nature.com/articles/s41537-024-00473-1
Discover the world at Altruu, The Discovery Engine